Bernard Chatelain Selected Research

Bernard Chatelain Research Topics

Disease

5	Venous Thromboembolism 12/2018 - 01/2013
4	Thrombosis (Thrombus) 07/2019 - 05/2012
4	Neoplasms (Cancer) 07/2013 - 01/2003
3	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2019 - 09/2015
3	Hemolysis 12/2018 - 09/2015
3	Disseminated Intravascular Coagulation 12/2018 - 03/2014
2	Activated Protein C Resistance (APC Resistance) 04/2018 - 12/2012
2	Thrombocytopenia (Thrombopenia) 12/2016 - 06/2010
1	Liver Failure 10/2020
1	Thrombophilia 04/2018
1	Hemorrhage 01/2015
1	Acute Promyelocytic Leukemia 03/2014
1	Acute Kidney Injury (Acute Renal Failure) 02/2014
1	Stroke (Strokes) 01/2014
1	Atrial Fibrillation 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Inflammation (Inflammations) 12/2012
1	Ischemia 12/2012
1	Hypoxia (Hypoxemia) 12/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2012
1	Genomic Instability 05/2012
1	Tics (Tic) 03/2012
1	Crohn Disease (Crohn's Disease) 01/2012
1	Hereditary Spherocytosis 07/2011
1	Drug-Related Side Effects and Adverse Reactions 01/2009
1	Lymphatic Metastasis 01/2003
1	Carcinoma (Carcinomatosis) 01/2003
1	Squamous Cell Carcinoma of Head and Neck 01/2003
1	Refractory Anemia with Excess of Blasts (RAEM) 10/2002
1	Refractory Anemia 10/2002
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2002

Drug/Important Bio-Agent (IBA)

4	eculizumab FDA Link 07/2019 - 09/2015
4	Biomarkers (Surrogate Marker)IBA 12/2018 - 01/2013
4	AnticoagulantsIBA 04/2018 - 01/2014
3	Indicators and Reagents (Reagents)IBA 10/2020 - 05/2012
3	Thrombin FDA Link 01/2018 - 03/2012
2	fibrin fragment D (D-dimer)IBA 12/2018 - 06/2014
2	Complement System Proteins (Complement)IBA 08/2017 - 09/2015
2	Dacarbazine (DIC)FDA LinkGeneric 02/2017 - 03/2014
2	Thromboplastin (Tissue Factor)IBA 02/2017 - 01/2013
2	Heparin (Liquaemin)FDA LinkGeneric 12/2016 - 06/2010
2	RivaroxabanIBA 01/2015 - 12/2012
1	Prothrombin (Factor II)IBA 10/2020
1	Complement C5 (Complement 5)IBA 12/2018
1	Factor Xa InhibitorsIBA 07/2018
1	Protein SIBA 04/2018
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 04/2018
1	AntithrombinsIBA 04/2018
1	Protein CIBA 04/2018
1	argatroban (MPQA)FDA Link 12/2016
1	apixabanIBA 01/2015
1	A 7 (A-7)IBA 01/2013
1	Fibrinogen (Factor I)FDA Link 12/2012
1	Clonidine (ST 155)FDA LinkGeneric 12/2012
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2012
1	Antithrombin ProteinsIBA 12/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2012
1	A-Form DNA (A-DNA)IBA 05/2012
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2012
1	Dabigatran FDA Link 05/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	Azathioprine (Imuran)FDA LinkGeneric 01/2012
1	Lipid Bilayers (Lipid Bilayer)IBA 07/2011
1	Purine NucleosidesIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	Cadherins (E-Cadherin)IBA 01/2003
1	Cell Adhesion MoleculesIBA 01/2003
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	HLA-DR Antigens (HLA-DR)IBA 10/2002

Therapy/Procedure

2	Therapeutics 12/2018 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2009